Description: ZILBRYSQ® is the first FDA-approved, self-administered treatment for adults with anti-AChR antibody-positive generalized myasthenia gravis (gMG).
domain name (202703) domains (76114) webhosting (45955) coming soon (10395) parkpage (9053) register.be (2089)
Important Safety Information
ZILBRYSQ REMS
Full Prescribing Information